Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanhong Su

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Science Advances|February 9, 2022
DExD/H-box helicase 9 intrinsically controls CD8<sup>+</sup> T cell-mediated antiviral response through noncanonical mechanismsAnjun Jiao, Chenming Sun, Xin Wang, et al.
Biochemical Pharmacology|June 2, 2021
C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinomaMei Yang, Yanhong Su, Zhiqiang Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2022
Med1 Controls Effector CD8<sup>+</sup> T Cell Differentiation and Survival through C/EBPβ-Mediated Transcriptional Control of T-betAnjun Jiao, Haiyan Liu, Renyi Ding, et al.
Cancer Communications (London, England)|April 23, 2026
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II StudyHaifeng Li, Meiting Chen, Riqing Huang, et al.
Immunology|December 18, 2021
Arid1a promotes thymocyte development through β-selection-dependent and β-selection-independent mechanismsXiaofeng Yang, Xin Wang, Lei Lei, et al.
Journal of Advanced Research|March 5, 2023
Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate speciesAnjun Jiao, Cangang Zhang, Xin Wang, et al.
Signal Transduction and Targeted Therapy|June 25, 2024
Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8<sup>+</sup> T cell effector differentiation and anti-tumor immunityLina Sun, Anjun Jiao, Haiyan Liu, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2025
VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and functionLe Tong, Apple Hui Min Tay, Weiyingqi Cui, et al.
Journal for Immunotherapy of Cancer|October 13, 2021
Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old miceCangang Zhang, Lei Lei, Xiaofeng Yang, et al.
Science Advances|May 15, 2026
Helicase A determines the transcription program of T<sub>H</sub>17 lineage differentiation and autoimmunityYanhong Su, Anjun Jiao, Xiaoran Zhang, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Science Advances|February 9, 2022
DExD/H-box helicase 9 intrinsically controls CD8<sup>+</sup> T cell-mediated antiviral response through noncanonical mechanismsAnjun Jiao, Chenming Sun, Xin Wang, et al.
Biochemical Pharmacology|June 2, 2021
C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinomaMei Yang, Yanhong Su, Zhiqiang Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2022
Med1 Controls Effector CD8<sup>+</sup> T Cell Differentiation and Survival through C/EBPβ-Mediated Transcriptional Control of T-betAnjun Jiao, Haiyan Liu, Renyi Ding, et al.
Cancer Communications (London, England)|April 23, 2026
Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II StudyHaifeng Li, Meiting Chen, Riqing Huang, et al.
Immunology|December 18, 2021
Arid1a promotes thymocyte development through β-selection-dependent and β-selection-independent mechanismsXiaofeng Yang, Xin Wang, Lei Lei, et al.
Journal of Advanced Research|March 5, 2023
Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate speciesAnjun Jiao, Cangang Zhang, Xin Wang, et al.
Signal Transduction and Targeted Therapy|June 25, 2024
Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8<sup>+</sup> T cell effector differentiation and anti-tumor immunityLina Sun, Anjun Jiao, Haiyan Liu, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2025
VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and functionLe Tong, Apple Hui Min Tay, Weiyingqi Cui, et al.
Journal for Immunotherapy of Cancer|October 13, 2021
Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old miceCangang Zhang, Lei Lei, Xiaofeng Yang, et al.
Science Advances|May 15, 2026
Helicase A determines the transcription program of T<sub>H</sub>17 lineage differentiation and autoimmunityYanhong Su, Anjun Jiao, Xiaoran Zhang, et al.
Pageof 6